News

GFAP, marcador plasmàtic clau per al futur diagnòstic de l’Alzheimer a la Síndrome de Down

Un estudi coliderat pel Dr. Daniel Alcolea, investigador de l'Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau – IIB Sant Pau i la Unitat de Memòria – Unitat Alzheimer-Down de l'Hosp...

A study reveals the existence of different patterns of cognitive progression in Huntington’s disease

Huntington's disease is a hereditary neurodegenerative disease caused by a mutation in a gene, which severely affects the cognitive ability of those who suffer from it. Traditionally, the way in which...

Sant Pau administrates a new CAR-T immunotherapy drug, self-produced, against B-cell lymphomas

The Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has developed a new CAR-T 19 immunotherapy drug that has just begun to be administered, as part of a clinical trial, t...

A new blood marker indicates inflammation in the carotid plaque and the risk of stroke recurrence

Inflammation of the carotid plaque is an important factor in the risk of recurrent stroke in patients with carotid artery disease. A study led by Dr. Vicenta Llorente, coordinator of the Lipids and Ca...

Using sensors to monitor inhalers improves adherence to asthma and COPD treatment

Electronic inhaler monitoring devices can significantly improve patient adherence to inhaled therapy in adults with asthma or chronic obstructive pulmonary disease (COPD), according to a study by rese...